I agree this is one sick puppy! It will need more than relanza to save it.Watch the cash burn rate :-( These guys are spending like there is no tomorrow.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress